Trulicity 3 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FDAFL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,790
Award facts
- Contract value 100% obligated
- $18,789.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $18,789.59. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's comprehensive portfolio under its DLA contracts encompasses a wide range of pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, and specialized medical supplies. Trulicity, a diabetes medication included in this delivery order, represents the type of specialty pharmaceutical commodities the company routinely supplies to support Defense Health Agency and other federal healthcare programs. The DLA's Pharmaceutical Prime Vendor Global Program is structured to support multiple regional contractors, positioning AmerisourceBergen as a key participant in the military medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FDAFL?
SPE2DB25FDAFL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FDAFL worth?
The government has obligated $18,790 on SPE2DB25FDAFL.
Is contract SPE2DB25FDAFL an order under another contract?
Yes. SPE2DB25FDAFL is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FDAFL competed?
The extent of competition for SPE2DB25FDAFL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award